Docetaxel (D) Plus Estramustine Monophosphate (Emp) In Patients (Pts) With Hormone Refractory Prostate Cancer (Hrpc).Thomas Nelius,F Reiher,T Lindenmeir, J Burandt,O Rau,Stephanie Filleur,Tobias Klatte,R Yap,Ernst Peter AllhoffJOURNAL OF CLINICAL ONCOLOGY(2005)引用 23|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要